Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide

Endocrine-Related Cancer - Tập 21 Số 5 - Trang 705-714 - 2014
Matthew H. Kulke1, Thomas M. O’Dorisio2, Alexandria T. Phan2, Emily K. Bergsland3, Linda Law2, Phillip Banks2, Joel Freiman2, Kenneth Frazier2, Jessica Jackson2, James C. Yao2, Larry K. Kvols2, Pablo Lapuerta2, Brian Zambrowicz2, Douglas Fleming2, Arthur Sands2
1Dana Farber Cancer Institute
2The University of Texas at Austin, Austin, United States
3University of California at San Francisco

Tóm tắt

Từ khóa


Tài liệu tham khảo

Beaumont, 2012, Pancreas, 41, 461, 10.1097/MPA.0b013e3182328045

1997, MMWR. Morbidity and mortality weekly report, 46, 1061

Connolly, 1997, New England Journal of Medicine, 337, 581, 10.1056/NEJM199708283370901

Creutzfeldt, 1996, World journal of surgery, 20, 126, 10.1007/s002689900020

2013, 8, e73679, 10.1371/journal.pone.0073679

2009, NATURE REVIEWS ENDOCRINOLOGY, 5, 276, 10.1038/nrendo.2009.51

Engelman, 1967, New England Journal of Medicine, 277, 1103, 10.1056/NEJM196711232772101

2005, Circulation, 111, 1517, 10.1161/01.CIR.0000159356.42064.48

Kvols, 1986, New England Journal of Medicine, 315, 663, 10.1056/NEJM198609113151102

2012, Endocrine-Related Cancer, 19, 657, 10.1530/ERC-11-0367

Melmon, 1965, Gastroenterology, 48, 18, 10.1016/S0016-5085(65)80089-0

Moller, 2003, New England Journal of Medicine, 348, 1005, 10.1056/NEJMoa021451

Thông tin
Thông tin xuất bản

Endocrine-Related Cancer

Tập 21 Số 5

705-714

Thông tin tác giả